Matching-adjusted indirect comparison of bosutinib, dasatinib and nilotinib effect on survival and major cytogenetic response in treatment of second-line chronic phase chronic myeloid leukemia
Jorge E. Cortes, Bogdan Muresan, Carla Mamolo, Joseph C. Cappelleri, Rocco J. Crescenzo, Yun Su, Carlo Gambacorti-Passerini, Bart Heeg, B. Douglas Smith
Dive into the research topics of 'Matching-adjusted indirect comparison of bosutinib, dasatinib and nilotinib effect on survival and major cytogenetic response in treatment of second-line chronic phase chronic myeloid leukemia'. Together they form a unique fingerprint.